Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics—A Preliminary Study

Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics—A Preliminary Study

Treatment of head and neck squamous cell carcinoma (HNSCC) has a detrimental impact on patient quality of life. The rate of recognized distress/depression among HNSCC patients ranges from 9.8% to 83.8%, and the estimated prevalence of depression among patients receiving radiotherapy is 63%. Shorter...

Full description

Bibliographic Details
Main Authors: Łukasz Boguszewicz, Alicja Heyda, Mateusz Ciszek, Agata Bieleń, Agnieszka Skorupa, Jolanta Mrochem-Kwarciak, Krzysztof Składowski, Maria Sokół
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Metabolites
Subjects:
HNSCC
radiotherapy
chemotherapy
distress
pain
metabolomics
Online Access:https://www.mdpi.com/2218-1989/14/1/60

Internet

https://www.mdpi.com/2218-1989/14/1/60

Similar Items